Article
Sulforaphane inhibits growth of phenotypically different breast cancer cells.
European journal of nutrition - 1 Dec 2013
Pawlik Anna, Wiczk Aleksandra, Kaczyńska Angelika, Antosiewicz Jędrzej, Herman-Antosiewicz Anna
Abstract excerpt
PURPOSE: Cancer development and resistance to chemotherapy correlates with aberrant activity of mitogenic pathways. In breast cancers, pro-survival PI3K-Akt-mTOR-S6K1 [corrected] signaling pathway is often hyperactive due to overexpression of genes coding for growth factors or estrogen receptors, constitutive activation of PI3K or Akt and loss of PTEN, a negative regulator of the pathway. Since epidemiologic as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
